The Prevalence of Hepatitis C Virus Antibodies among Hemodialysis Patients
1990; American College of Physicians; Volume: 112; Issue: 12 Linguagem: Inglês
10.7326/0003-4819-112-12-958
ISSN1539-3704
Autores Tópico(s)Renal Transplantation Outcomes and Treatments
ResumoBrief Reports15 June 1990The Prevalence of Hepatitis C Virus Antibodies among Hemodialysis PatientsJerome B. Zeldis, MD, PhD, Thomas A. Depner, MD, I. K. Kuramoto, BS, Robert G. Gish, MD, Paul V. Holland, MDJerome B. Zeldis, MD, PhD, Thomas A. Depner, MD, I. K. Kuramoto, BS, Robert G. Gish, MD, Paul V. Holland, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-12-958 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe incidence of viral hepatitis in hemodialysis units has declined over the past 20 years with improved infection control strategies, including patient surveillance and segregation, plus improved prophylaxis with immune globulin, hepatitis B immune globulin, hepatitis B vaccines, and disinfectant procedures (1). Despite these measures, some hemodialysis patients have transient or prolonged elevations of their aminotransferase levels. Furthermore, end-stage liver disease is a major cause of death in long-term survivors of renal transplantation (2). Non-A, non-B hepatitis appears to be the major cause of hepatitis in hemodialysis units. Recently, a viral agent, hepatitis C virus (HCV), was isolated that may...References1. AlterFaveroMaynard MMJ. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis. 1986;153:1149-51. CrossrefMedlineGoogle Scholar2. BoyceHoldsworthHookeThomsonAtkins NSDNR. Nonhepatitis B-associated liver disease in a renal transplant population. Am J Kidney Dis. 1988;11:307-12. CrossrefMedlineGoogle Scholar3. ChooKuoWeinerOverbyBradleyHoughton QGALDM. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-62. CrossrefMedlineGoogle Scholar4. KuoChooAlter GQH. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-4. CrossrefMedlineGoogle Scholar5. EstebanEstebanViladomiu JRL. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989;2:294-7. CrossrefMedlineGoogle Scholar6. van derReesinkLelie PCHP. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet. 1989;2:297-8. CrossrefMedlineGoogle Scholar7. SnedecorCochran GW. Statistical Methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: From the University of California, Davis, Medical Center, Sacramento, California; Pacific Presbyterian Medical Center, San Francisco, California; and the Center for Blood Research, Sacramento Medical Foundation Blood Center, Sacramento, California. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFactors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis Patients—Findings Mainly from Asiatic Populations: A Systematic Review and Meta-AnalysisAPASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?The association of hepatitis C infection with the onset of CKD and progression into ESRDHigh Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney diseaseGlecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentHepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern IranPrevalence of Hepatitis B and C among Hemodialysis Patients of Tripura, IndiaChronic hepatitis C genotype 4 treatment in chronic haemodialysis patients: A retrospective studyA shield against a monster: Hepatitis C in hemodialysis patientsThe treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplantHepatitis C Virus Infection in Hemodialyzed PatientsAcute Hepatitis C in Patients Receiving HemodialysisLow risk of sexual transmission of hepatitis C virus to spouses of infected hemodialysis patientsPrise en charge de l'infection par les virus des hépatites B ou C chez l'insuffisant rénal chroniqueHepatitis C Virus Infection in Haemodialysis Patients: "Wolf in Sheep's Clothing"Hepatitis C infection is acquired pre-ESRDChronic viral hepatitis in hemodialysis patientsClinical Usefulness of a New Hepatitis C Virus RNA Extraction Method Using Specific Capture Probe and Magnetic Particle in Hemodialysis PatientsNatural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-upChanges in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?Sonographic Features of Hepatic Artery Calcification in Chronic Renal FailurePrevalence of Hepatitis C Virus Infection Among Haemodialysis Patients in West Java, IndonesiaThe Epidemiology of Hepatitis C Virus InfectionGlobal epidemiology and burden of hepatitis CHCV infection and hemodialysisHigh Prevalence of Hepatitis C Infection Among Patients Receiving Hemodialysis at an Urban Dialysis CenterImpact of hepatitis B and C on graft loss and mortality of patients after kidney transplantationCase-control study of calcification of the hepatic artery in chronic hemodialysis patients: Comparison with the abdominal aorta and splenic arterySevere evolution of chronic hepatitis C in renal transplantation: a case control studyCommunity-based seroepidemiological survey of HCV infection in Catalonia, SpainDiagnostic Workup of Hepatitis C and the Patient on Maintenance DialysisThe tolerance and efficacy of interferon‐α in haemodialysis patients with HCV infection: a multicentre, prospective studyHepatitis C Virus Infection in Dialysis: An Emerging Clinical RealityHepatitis C Virus in Blood and Dialysate in HemodialysisLiver Disease in Dialysis PatientsSerotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patientsMembrane Compatibility, Flux and HCV Infection in Dialysis Patients: Newer EvidenceAutoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificiallyPrevalence of subclinical cryoglobulinemia in maintenance hemodialysis patients and kidney transplant recipientsSuperinfection of TT virus and hepatitis C virus among chronic haemodialysis patientsHepatitis C genotypes and subtypes in Saudi ArabiaTransarterial chemoembolization for hepatocellular carcinoma arising in a hepatitis C virus-seropositive renal allograft recipientPrimary amyloidosis complicated by systemic necrotizing arteritisProspective virological follow‐up of hepatitis C infection in a haemodialysis unitHepatitis C Virus and HIV CoinfectionHepatitis in the Renal PatientAcute hepatitis C among renal failure patients on chronic haemodialysisPrevalence of hepatitis B and hepatitis C in haemodialysis patientsHEPATITIS C INFECTION IN TRANSPLANTATIONGB virus-C infection among chronic haemodialysis patients: Clinical implicationsHepatitis in patients with end-stage renal diseaseAdsorption of Hepatitis C Virus Particles Onto the Dialyzer MembraneHepatitis C in renal transplanationHistopathological Impacts of Hepatitis Virus Infection in Hemodialysis Patients: Should Liver Biopsy Be Performed Before Renal Transplantation?Hepatitis C virus infection in dialysis and renal transplantationSoroprevalência do vírus da hepatite C na população em diálise de Goiânia, GOInfectious Diseases: Interferon Alfa in the Treatment of Chronic Viral Hepatitis B and CHepatitis G virus infection in hemodialysis patientsNonhepatic manifestations and combined diseases in HCV infectionLow prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: A multicenter analysisDestruction of hepatitis C virus particles by haemodialysisPhylogenetic analysis of hepatitis C virus isolates from hemodialysis patientsInfrafamilial infection with hepatitis C virusAnti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groupsHepatitis C virus infection: clinical aspects and treatment with interferon alfaHepatitis C and the Renal Transplant PatientGastrointestinal function in chronic renal failureHEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENTHBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysisInterferon treatment for chronic hepatitis C in haemodialysis patients: Suggestions based on a small seriesMode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patientsChronic viral hepatitis and the management of chronic renal failureEfficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patientsHepatitis C Virus Infection in Dialysis and Clinical NephrologyNew insights into hepatitis C virus infection of hemodialysis patients: the implicationsMarkers of Hepatitis C Infection among Hemodialysis Patients with Acute and Chronic Infection: Implications for Infection Control Strategies in Hemodialysis UnitsTransmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplantHepatitis C virus: The nephrologist's viewQuantitation of Hepatitis C Viral RNA in Sera of Hemodialysis Patients: Gender-Related Differences in Viral LoadPrevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant womenHCV-RNA and anti-HCV immune response in haemodialysis patients: correlation with hepatocytolysis parametersHEPATITIS INFECTION IN IMMUNOCOMPROMISED PATIENTSA Dialysis Case Presentation and DiscussionImmunological Aspects of HaemodialysisPrevalence and role of hepatitis C viraemia in haemodialysis patients in JapanHepatitis C virus infection in haemodialysis patients: a clinical and virological studyHepatitis C Virus in the Hemodialysis Setting: A Review with Recommendations for ControlViral Hepatitis in the Compromised HostManagement of chronic hepatitis in special populationsHepatitis C infection unrelated to blood transfusion in hemodialysis patientsThe impact of hepatitis C virus infection on renal allograft recipientsHepatitis C Virus Infections in Dialysis Units: Prevalence of HCV-RNA and Antibodies to HCVLiver Disease Patterns in Hemodialysis Patients With Antibodies to Hepatitis C VirusHigh frequency of antibodies to Hantaan virus and hepatitis C virus in chronic haemodialysis patients Coincidence or cross-reaction?Virological features of hepatitis C virus infection in hemodialysis patientsDecline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major.Multicenter Study of Hepatitis C Virus Infection in Chronic Hemodialysis Patients and Hemodialysis Center Staff MembersHepatitis C infection in children and adolescents on haemodialysis and after renal transplantHepatitis C markers in hemodialysis patientsHepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virusHigh Incidence of Hepatitis C Virus Infection in Hemodialysis Patients in TaiwanHepatitis C in the health care setting. II. Seroprevalence among hemodialysis staff and patients in suburban New York CityPrevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody AssaysPrevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis C virus RNA in plasmaEpidemiology of hepatitis C virus infectionHigh Prevalence of Antibodies to Hepatitis C Virus among Family Members of Patients with Anti-HCV-Positive Chronic Liver DiseaseImproved Detection of Antibodies to Hepatitis C Virus in Dialysis Patients Using a Second-Generation Enzyme ImmunoassayShould Patients With Hepatitis C Virus Antibodies In Chronic Hemodialysis Be Isolated?Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for themPrevalence of anti-HCV and HCV viremia in hemodialysis patients in TaiwanEmergency department evaluation and management of dialysis patient complicationsRisk factors for dialysis-associated hepatitis C in VenezuelaSeropositivity to Hepatitis C Virus in Saudi Haemodialysis PatientsSeropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysisProblematiche Inerenti L'epatite C Nei Centri DialisiOverestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored seraPrevalence and significance of antibodies to hepatitis c virus among Saudi haemodialysis patientsHepatitis C virus infection among kidney transplant recipientsTransmission of Hepatitis C Virus by Organ TransplantationHepatitis C virus antibodies among risk groups in TurkeyPrevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virusHepatitis C in Patients Undergoing Liver TransplantationAlexandra E. Read, MD, Elizabeth Donegan, MD, John Lake, MD, Linda Ferrell, MD, Cynthia Galbraith, RN, I. K. Kuramoto, BS, Jerome B. Zeldis, MD, PhD, Nancy L. Ascher, MD, PhD, John Roberts, MD, Teresa L. Wright, BM, BSHepatitis C-virus (HCV) antibodies in patients after kidney transplantationNon-A, Non-B Hepatitis in Dialysis Patients: Diagnosis, Prevention and Treatment 15 June 1990Volume 112, Issue 12Page: 958-960KeywordsBloodGlobulinsHepatitisHepatitis BHepatitis C virusLiver diseasesMedical dialysisProphylaxisRenal transplantationVaccines ePublished: 1 December 2008 Issue Published: 15 June 1990 PDF downloadLoading ...
Referência(s)